Background: The alarming increase in sugar consumption worldwide has largely contributed
towards the escalating symptoms of metabolic syndrome (MetS) such as obesity, insulin …

Background The metabolic syndrome, known also as the insulin resistance syndrome, refers
to the clustering of several risk factors for atherosclerotic cardiovascular disease …

Abstract Background The metabolic syndrome (MetS) is a cluster of metabolic abnormalities
comprising visceral obesity, dyslipidaemia and insulin resistance (IR). With the onset of IR …

Objective To investigate the effects of glycyrrhizic acid supplementation on glucose and lipid
metabolism in rodents consuming a high-fat, high-sucrose diet. Methods Twenty-four male, 8 …

Glycyrrhizic acid (GA) ameliorates many components of the metabolic syndrome, but its
potential therapeutic use is marred by edema caused by inhibition of renal 11β …

Glycyrrhizic acid (GA) has been reported to inhibit postprandial blood glucose rise and 11 β-
hydroxysteroid dehydrogenase 1 (11 βHSD1) activity. As not much work has been done on …

The activities of phosphoenolpyruvate carboxykinase (PEPCK) are influenced by active
glucocorticoids which are activated by 11-β-hydroxysteroid dehydrogenase 1 (11β-HSD1) …

Studies on ligand binding potential of glycyrrhizic acid, a potential agonist to PPARγ,
displayed encouraging results in amelioration of metabolic syndrome. The regulation of …

Stress and high-calorie diets increase the risk of developing metabolic syndrome.
Glycyrrhizic acid (GA) has been shown to improve dyslipidaemia in rats fed on a high-calorie …

The aim of this study was to examine the role of glycyrrhetic acid (GE) as a potential
compound in the amelioration of metabolic syndrome. Rats given intraperitoneal injection of …